6 insiders reported 11 Form 4 transactions for PMV Pharmaceuticals, Inc. (PMVP) over the past 18 months (most recent 2025-10-29). Recent activity: Mack David Henry (President and CEO) Buy 220,643 shares, ORBIMED ADVISORS LLC (Insider) Sell 1.0M shares, OrbiMed Capital GP V LLC (Insider) Sell 1.0M shares, ORBIMED ADVISORS LLC (Insider) Sell 500,000 shares, OrbiMed Capital GP V LLC (Insider) Sell 500,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-29 | Mack David Henry | President and CEO | Buy | 220,643 | $302,281 |
| 2025-10-27 | ORBIMED ADVISORS LLC | Insider | Sell | 1.0M | $1.5M |
| 2025-10-27 | OrbiMed Capital GP V LLC | Insider | Sell | 1.0M | $1.5M |
| 2025-09-12 | ORBIMED ADVISORS LLC | Insider | Sell | 500,000 | $900,000 |
| 2025-09-12 | OrbiMed Capital GP V LLC | Insider | Sell | 500,000 | $900,000 |
| 2025-07-03 | Carulli Michael | Chief Financial Officer | Sell | 28,249 | $29,944 |
| 2025-07-03 | Jalota Deepika | Chief Development Officer | Sell | 33,065 | $35,049 |
| 2025-07-03 | Mack David Henry | President and CEO | Sell | 58,411 | $61,916 |
| 2025-07-03 | Ticktin Robert | General Counsel & COO | Sell | 23,151 | $24,540 |
| 2025-01-22 | Mack David Henry | President and CEO | Buy | 91,750 | $48,628 |
| 2025-01-22 | Mack David Henry | President and CEO | Buy | 17,709 | $9,386 |
Source: SEC Form 4 filings · as of 2025-10-29